Cargando…

Introduction and evaluation of multidrug-resistant tuberculosis supplemental surveillance in the United States()

The current tuberculosis (TB) case reporting system for the United States, the Report of Verified Case of TB (RVCT), has minimal capture of multidrug-resistant (MDR) TB treatment and adverse events. Data were abstracted in five states using the form for 13 MDR TB patients during 2012–2015. The Cente...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belanger, Annie, Morris, Sapna Bamrah, Brostrom, Richard, Yost, David, Goswami, Neela, Oxtoby, Margaret, Moore, Marisa, Westenhouse, Janice, Barry, Pennan M., Shah, Neha S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830138/ https://www.ncbi.nlm.nih.gov/pubmed/31720417 http://dx.doi.org/10.1016/j.jctube.2019.01.005

Ejemplares similares

1392. Tuberculosis Disease in Recipients of Organ-Transplantation, California 2010–2017
por: Katrak, Shereen, et al.
Publicado: (2019)

Interferon-γ Release Assay Performance in Pediatric Tuberculosis Disease in California
por: Kay, Alexander, et al.
Publicado: (2017)

Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017
por: Lardizabal, Alfred A., et al.
Publicado: (2018)

1881. Costs of Treating Multidrug Resistant Tuberculosis in California, 2022
por: Katrak, Shereen, et al.
Publicado: (2023)

Assessing the validity of tuberculosis surveillance data in California
por: Sprinson, Joan E, et al.
Publicado: (2006)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
por: Katrak, Shereen, et al.
Publicado: (2021)

Multisystem Inflammatory Syndrome in Adults: Coming Into Focus
por: Tenforde, Mark W., et al.
Publicado: (2021)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Increasing Prevalence of Nontuberculous Mycobacteria in Respiratory Specimens from US-Affiliated Pacific Island Jurisdictions
por: Lin, Chunrong, et al.
Publicado: (2018)

Notes from the Field: Meningeal and Pulmonary Tuberculosis on a Commercial Fishing Vessel — Hawaii, 2017
por: Imada, Erin K., et al.
Publicado: (2019)

Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness
por: Nwana, Nwabunie, et al.
Publicado: (2019)

Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022
por: O’Shea, Jesse, et al.
Publicado: (2022)

Introduction to Surveillance Studies
por: Petersen, JK
Publicado: (2012)

Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013–2018
por: McDowell, Ashley, et al.
Publicado: (2020)

Engaging Experts: Science-Policy Interactions and the Introduction of Congestion Charging in Stockholm
por: Broström, Anders, et al.
Publicado: (2017)

Surveillance Systems that Include Deprivation Indices & Social Determinants of Health
por: Moore, Kieran, et al.
Publicado: (2016)

Use of Nucleic Acid Amplification Tests in Tuberculosis Patients in California, 2010–2013
por: Peralta, Gianna, et al.
Publicado: (2016)

Assessing Complexity Among Patients With Tuberculosis in California, 1993–2016
por: Vaisman, Alon, et al.
Publicado: (2020)

Health insurance, healthcare utilization and language use among populations who experience risk for tuberculosis, California 2014–2017
por: Readhead, Adam, et al.
Publicado: (2022)

Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013
por: Shah, Neha S., et al.
Publicado: (2016)

Tuberculosis Treatment Managed by Providers outside the Public Health Department: Lessons for the Affordable Care Act
por: Ehman, Melissa, et al.
Publicado: (2014)

Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019
por: Sosa, Lynn E., et al.
Publicado: (2019)

Molecular Surveillance for Multidrug-Resistant Plasmodium falciparum, Cambodia
por: Shah, Naman K., et al.
Publicado: (2008)

Increased risk of tuberculosis among foreign-born persons with diabetes in California, 2010–2012
por: Demlow, Sarah Ellen, et al.
Publicado: (2015)

Association of Area-Based Socioeconomic Measures with Tuberculosis Incidence in California
por: Bakhsh, Yasser, et al.
Publicado: (2022)

Catching Breath: The Making and Unmaking of Tuberculosis
por: Oxtoby, Margaret J., et al.
Publicado: (2018)

Women's Health Surveillance Report: Introduction
por: DesMeules, Marie, et al.
Publicado: (2004)

Introduction to Public Health Surveillance Course
Publicado: (2013)

Multiple Introductions of Multidrug-Resistant Tuberculosis into Households, Lima, Peru
por: Cohen, Ted, et al.
Publicado: (2011)

Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013)

Performance of Multidrug-Resistant Tuberculosis Surveillance in Yemen: Interview Study
por: Abdulmughni, Jihan, et al.
Publicado: (2019)

Death With Tuberculosis in California, 1994–2008
por: Pascopella, Lisa, et al.
Publicado: (2014)

A systematic synthesis of direct costs to treat and manage tuberculosis disease applied to California, 2015
por: Oh, Peter, et al.
Publicado: (2017)

1400. Pretomanid in the Treatment of Patients with Tuberculosis in the United States: the Bedaquiline, Pretomanid and Linezolid (BPaL) Accelerated Monitoring (BAM) Project
por: Goswami, Neela, et al.
Publicado: (2021)

Evolution of tuberculosis/HIV co-infection in California during the HAART Era, 1996-2007
por: Metcalfe, John, et al.
Publicado: (2010)

Reporting of a surveillance system of multidrug-resistant organisms in an Italian hospital
por: D'Errico, MM, et al.
Publicado: (2011)

Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance
por: Gazzarata, Roberta, et al.
Publicado: (2020)

Getting to Zero: Tuberculosis Elimination in California
por: Barry, Pennan M., et al.
Publicado: (2016)

Notes from the Field: Hepatitis A Outbreak Associated with Drug Use and Homelessness — West Virginia, 2018
por: Wilson, Erica, et al.
Publicado: (2019)

Identification and description of patients with multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection using the Premier Healthcare Database
por: DeCuir, Jennifer, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_navkm0gjqjon6fmi9jndh8nott